Young Cha

Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease”.

Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease

New England Journal of Medicine(2020)10.1056/nejmoa1915872

N/A

0DataRank · unranked

528 citations

Bin Song, Todd M. Herrington, Tae Yoon Park, Nayeon Lee, Sanghyeok Ko +20 more

SIRT2 regulates mitochondrial dynamics and reprogramming via MEK1-ERK-DRP1 and AKT1-DRP1 axes

Cell Reports(2021)10.1016/j.celrep.2021.110155

N/A

0DataRank · unranked

66 citations

Taewoo Kim, Jeha Jeon, Yongwoo Jang, Patrick B. Kim, Claúdia Lopes +4 more

Spotting-based differentiation of functional dopaminergic progenitors from human pluripotent stem cells

Nature Protocols(2022)10.1038/s41596-021-00673-4

N/A

0DataRank · unranked

23 citations

Jeha Jeon, Bin Song, Nayeon Lee, Sanghyeok Ko, Young Cha +4 more

Integrative analysis of mitochondrial metabolic dynamics in reprogramming human fibroblast cells

STAR Protocols(2022)10.1016/j.xpro.2022.101401

N/A

0DataRank · unranked

2 citations

Pierre Leblanc, Yean Ju Hong, Kwang‐Soo Kim, Young Cha

Co-transplantation of autologous Treg cells in a cell therapy for Parkinson’s disease

Nature(2023)10.1038/s41586-023-06300-4

N/A

0DataRank · unranked

122 citations

Jeha Jeon, Nayeon Lee, Jisun Kim, Bin Song, Jung-Ho Kim +10 more

An optimized Nurr1 agonist provides disease-modifying effects in Parkinson’s disease models

Nature Communications(2023)10.1038/s41467-023-39970-9

N/A

0DataRank · unranked

48 citations

Mohit Tripathi, Chun‐Hyung Kim, Satyapavan Vardhineni, Young Cha, Shamseer Kulangara Kandi +15 more

Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease

Journal of Movement Disorders(2023)10.14802/jmd.22141

N/A

0DataRank · unranked

42 citations

Tae Yoon Park, Pierre Leblanc, Kwang‐Soo Kim, Young Cha

Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses

Cell Research(2024)10.1038/s41422-024-00971-y

N/A

0DataRank · unranked

28 citations

Jeha Jeon, Young Cha, Kwang‐Soo Kim, Tae Yoon Park

Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease

Cell stem cell(2025)10.1016/j.stem.2025.01.006

N/A

0DataRank · unranked

28 citations

Young Cha, Yean Ju Hong, In-Hee Lee, HeeJin Jang, Sanghyeok Ko +17 more

A new era in regenerative medicine: Cell replacement therapy for Parkinson’s disease is on the horizon

Cell stem cell(2025)10.1016/j.stem.2025.05.005

N/A

0DataRank · unranked

3 citations

Pierre Leblanc, Kwang‐Soo Kim, Young Cha